‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker
Source:
financialTimes
August 3, 2026 · 21:00
Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs
The original article opens on the publisher's website.
More from General
View topic →Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group
bbcTechnology
Sep 1, 2026 · 18:27
Massachusetts’ 80-year-old senator sees off primary challenge over his age
financialTimes
Sep 1, 2026 · 18:06
Pentagon chaos deepens after Driscoll quits in clash with Hegseth
financialTimes
Sep 1, 2026 · 17:47
Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate
nprNews
Sep 1, 2026 · 17:38
Apple Maps changes Lake Ontario to Lake America after Trump order
bbcTechnology
Sep 1, 2026 · 17:36